Liquid Biopsy 2017 Global Market Expected to Grow at CAGR Of 20.31% and Forecast to 2021

Wiseguyreports.Com Publish New Market Research Report On-“Liquid Biopsy 2017 Global Market Expected to Grow at CAGR Of 20.31% and Forecast to 2021”.

Liquid Biopsy Market 2017

Executive Summary
Like prostate cancer, other cancer cases such as lung cancer and breast cancer are increasing. To treat the disease at its early stage, liquid biopsies are performed, which helps in the detection of cancer. An increasing number of cancer cases will increase the need for liquid biopsy in the market. The skilled lab technicians are required to handle liquid biopsy systems such as polymerase chain reactions (PCRs) and assays. However, shortage of skilled physicians and lab technicians is one of the major challenges in the market. Lack of skilled technicians is a common challenge in hospitals and diagnostic laboratories in many developing and underdeveloped countries in APAC and the Sub-Saharan region. This will pose a major threat, as improper testing can lead to errors in the test results.

The analysts forecast the global liquid biopsy market to grow at a CAGR of 20.31% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global biopsy market market for 2017-2021. To calculate the market size, the report considers the considers the global demand for liquid biopsy.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA


Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1120155-global-liquid-biopsy-market-2017-2021


The report, Global Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Biocept
• Exosome Diagnostics
• QIAGEN
• Roche Molecular Diagnostics

Other prominent vendors
• AccuraGen
• Agena Bioscience
• Bio-Rad Laboratories
• CellMax Life
• Chronix Biomedical
• Clearbridge BioMedics
• Circulogene Theranostics
• Cynvenio Biosystems
• Epic Sciences
• Freenome
• Genomic Health
• Natera
• Novogene
• OncoCyte
• Pathway Genomics
• Personal Genome Diagnostics
• RainDance Technologies
• Sequenom
• Sysmex
• Thermo Fisher Scientific
• Transgenomic
• Vermillion
• WaveSense

Market driver
• Increasing prevalence of cancer cases in older population
• For a full, detailed list, view our report

Market challenge
• Dearth of skilled professionals, laboratory technicians, and oncologists
• For a full, detailed list, view our report

Market trend
• Venture capitalists for market entry of start-ups
• For a full, detailed list, view our report


Complete Report Details @ https://www.wiseguyreports.com/reports/1120155-global-liquid-biopsy-market-2017-2021


Table of Contents – Key Points Analysis

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
• Biopsy
• Liquid biopsy: Future of cancer diagnostics

PART 05: Market landscape
• Market overview
• Clinical trials
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• CTCs and ctDNA
• Exosomes and RNA

PART 07: Market segmentation by end-user
• Global liquid biopsy market by end-user in 2016
• Hospitals
• Clinical diagnostic laboratories
• Physicians' office laboratories

PART 08: Geographical segmentation
• Liquid biopsy market in Americas
• Liquid biopsy market in US
• Liquid biopsy market in EMEA
• Liquid biopsy market in UK
• Liquid biopsy market in APAC
• Liquid biopsy market in China

PART 09: Market drivers
• Increasing prevalence of cancer cases in older population
• Government initiatives and pilot programs
• Collaboration between companies for co-development of products

PART 10: Impact of drivers
PART 11: Market challenges
• Lack of reimbursement
• Dearth of skilled professionals, laboratory technicians, and oncologists
• High cost of clinical trials and failure rate in clinical trials

PART 12: Impact of drivers and challenges
PART 13: Market trends
..…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1120155

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt. Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349
Website: http://www.wiseguyreports.com

Release ID: 236001